Hep Email Update People With Alcohol Use Disorders Face Barriers to Hepatitis C Treatment Even those with a history of heavy alcohol use who are currently abstinent have trouble receiving treatment. Lean People With NAFLD May Have Higher Mortality Risk Most outcomes were similar in lean and heavy people with fatty liver disease, but the lean group had higher liver-related mortality. Have you ever participated in a clinical trial? Please take our poll! Advertisement Health Policies Were a Prominent Theme in Biden’s State of the Union Speech Biden warned about Republicans trying to phase out Medicare and Social Security. Here, PolitiFact checks that claim and others. Bivalent Boosters Provide Better Protection Against Severe COVID-19 Increased protection against hospitalization or death was seen regardless of age or history of previous boosters. Hep A Outbreaks Our map outlines where in the United States active cases of hepatitis A have been reported in the past 12 months on a scale from 0 to 100 relative to other states. Advertisement Science News People With Alcohol Use Disorders Face Barriers to Hepatitis C Treatment Bivalent Boosters Provide Better Protection Against Severe COVID-19 Lean People With NAFLD May Have Higher Mortality Risk Abstaining From Alcohol Improves Outcomes in People With Cirrhosis Newsfeed Reduce Liver Fat With 150 Minutes of Aerobic Exercise Per Week Health Policies Were a Prominent Theme in Biden’s State of the Union Speech Fast Food Linked to Liver Disease Fewer Medi-Cal Patients Receiving Hepatitis C Treatment Science News People With Alcohol Use Disorders Face Barriers to Hepatitis C Treatment Bivalent Boosters Provide Better Protection Against Severe COVID-19 Lean People With NAFLD May Have Higher Mortality Risk Abstaining From Alcohol Improves Outcomes in People With Cirrhosis Newsfeed Reduce Liver Fat With 150 Minutes of Aerobic Exercise Per Week Health Policies Were a Prominent Theme in Biden’s State of the Union Speech Fast Food Linked to Liver Disease Fewer Medi-Cal Patients Receiving Hepatitis C Treatment

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: